Back
Nektar Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
NKTR
Nektar Therapeutics
Last Price:
1.02
Seasonality Move:
15.74%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.16 | Sell |
| 20-day SMA: | 1.26 | Sell |
| 50-day SMA: | 1.28 | Sell |
| 200-day SMA: | 1.23 | Sell |
| 8-day EMA: | 1.13 | Sell |
| 20-day EMA: | 1.22 | Sell |
| 50-day EMA: | 1.26 | Sell |
| 200-day EMA: | 1.22 | Sell |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 29.72 | Sell |
| Chaikin Money Flow: | -1485536 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.16 - 1.42) | Sell |
| Bollinger Bands (100): | (1.18 - 1.38) | Sell |
Nektar Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
- Nektar Therapeutics share price is 1.00 while NKTR 8-day simple moving average is 1.16, which is a Sell signal.
- The stock price of NKTR is 1.00 while Nektar Therapeutics 20-day SMA is 1.26, which makes it a Sell.
- Nektar Therapeutics 50-day simple moving average is 1.28 while NKTR share price is 1.00, making it a Sell technically.
- NKTR stock price is 1.00 and Nektar Therapeutics 200-day simple moving average is 1.23, creating a Sell signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
30
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a Sell
The current Nektar Therapeutics [NKTR] share price is $1.00. The Score for NKTR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
184.46M
Price in USD:
1.00
Share Volume:
1.49M
Nektar Therapeutics 52-Week Range
52-Week High:
1.93
52-Week Low:
0.42
Sell
30
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?
The Nektar Therapeutics stock price is 1.00 USD today. -
Will NKTR stock go up or go down?
Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Nektar Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
- Nektar Therapeutics share price is 1.00 while NKTR 8-day exponential moving average is 1.13, which is a Sell signal.
- The stock price of NKTR is 1.00 while Nektar Therapeutics 20-day EMA is 1.22, which makes it a Sell.
- Nektar Therapeutics 50-day exponential moving average is 1.26 while NKTR share price is 1.00, making it a Sell technically.
- NKTR stock price is 1.00 and Nektar Therapeutics 200-day simple moving average is 1.22, creating a Sell signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and a decrease next year of $0.08 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
- NKTR Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting Nektar Therapeutics is a Sell
- Nektar Therapeutics Relative Strength Index (RSI) is 29.72, which suggest Nektar Therapeutics is oversold
- The Bollinger Bands (25) for Nektar Therapeutics is (1.16 - 1.42), which suggest Nektar Therapeutics is a Sell
- The Bollinger Bands (100) for Nektar Therapeutics is (1.18 - 1.38), which suggest Nektar Therapeutics is a Sell
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.